TC

Transhuman Capital

North America, Michigan, United States, Ann Arbor

Description

Transhuman Capital is a venture capital firm that invests in pharmaceuticals, medical devices, and other technologies.

Investor Profile

Transhuman Capital has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series B (33%)
  • Series A (33%)
  • Series C (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Transhuman Capital frequently co-invest with?

Amplo
North America, Texas, United States, Spring
Co-Investments: 2
Narya Capital
North America, Ohio, United States, Columbus
Co-Investments: 3
Patient Square Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Bluebird Ventures
North America, California, United States, Palo Alto
Co-Investments: 3
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 3
CAM Capital
North America, New York, United States, New York
Co-Investments: 2
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 3
QVT Financial
North America, New York, United States, New York
Co-Investments: 3
Dexcel Pharma
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 3
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2

Which angels does Transhuman Capital often collaborate with?

PM
North America, Virginia, United States, Charlottesville
Shared Deals: 1

What are some of recent deals done by Transhuman Capital?

Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series CMay 16, 2022
Amount Raised: $270,000,000
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series BJul 14, 2021
Amount Raised: $100,000,000
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series AMay 12, 2020
Amount Raised: $80,500,000